The Role of Viruses in the Development of Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Infectious Agents and Cancer".
Deadline for manuscript submissions: 31 March 2025 | Viewed by 108
Special Issue Editor
Special Issue Information
Dear Colleagues,
We are pleased to invite you to contribute a paper for this Special Issue on “The Role of Viruses in the Development of Cancer”. Viruses have been studied as etiological agents in the development of animal and human cancers for more than a century. This work has aided the identification of oncogenes and tumour suppressor genes as well as highlighting viruses that play a crucial role in the development of human cancers, for example, the role of high-risk human papillomaviruses (HPVs) in ano-genital and oral cancers, and of the human retrovirus T-lymphotropic virus 1 (HTLV 1) in adult T-cell leukaemia (ATL). The field continues to be buoyant, with new tumour viruses such as the DNA viruses, Merkel Cell Polyomavirus (MCPyV) and Kaposi’s sarcoma herpesvirus (KSHV or HHV8) being discovered using DNA sequence and genomic analysis within the past two decades. While effective prophylactic vaccines have been developed against HPVs and Hepatitis B (HBV), there is still a requirement for novel therapeutic approaches to human cancers that are driven by tumour virus infection.
Original research articles and reviews are welcome in this Special Issue. Research areas may include (but are not limited to) fundamental studies on the molecular mechanisms of cell transformation and oncogenesis by DNA and RNA tumour viruses; the immune response to tumour viruses; the immune evasion of cancers driven by tumour viruses; prophylactic and therapeutic vaccines against tumour viruses and the cancers that they cause; emerging tumour viruses; and global perspectives on tumour viruses and cancers.
We look forward to receiving your contributions.
Prof. Dr. George Eric Blair
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- DNA and RNA tumour viruses
- HPV
- EBV
- KSHV
- HCV
- HBV
- HTLV1
- McPyV
